BTN/L-Fc-CD19scFv

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameBTN/L-Fc-CD19scFv
Drug Alias NameBTN/L x CD19 (Shattuck Labs)anti-Vg9d2 TCR/anti-CD19 gamma delta T-cell engager (Shattuck Labs)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > T cell engagers
Mechanisms of ActionB-lymphocyte antigen CD19 modulatorsT-cell receptor modulators
TargetsT-cell receptorB-lymphocyte antigen CD19
Therapy Area/IndicationsLymphomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShattuck Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShattuck Labs Inc
Active IndicationsN/A
Inactive IndicationsLymphomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A